GlassScriptPhysician profile
Avery Jacqueline Platt
NPI 1851975718
$2,581.92
in general payments reported to CMS, 2019-2025
17 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.41 · 2022: $256 · 2023: $718 · 2024: $443 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.62 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $536.54 | 2022-2025 | Infuse, Btod, Vyzulta |
| Alcon Vision LLC | $457.16 | 2021-2025 | Precision7, Precision 1, Dailies Total1 |
| Coopervision INC. | $326.03 | 2023-2025 | Myday Contact Lens, Misight Contact Lens, Synergeyes Contact Lens |
| Amgen INC. | $179.73 | 2025 | Tepezza |
| Biotissue Holdings INC. | $175.55 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $150.73 | 2025 | Xdemvy |
| Astellas Pharma US INC | $150.00 | 2023-2025 | Izervay |
| Johnson & Johnson Vision Care, INC. | $149.80 | 2024-2025 | |
| Abbvie INC. | $132.31 | 2022-2024 | |
| Apellis Pharmaceuticals, INC. | $110.19 | 2023 | Syfovre |
| Abb Con-Cise Optical Group LLC | $65.06 | 2025 | Contact Lens |
| Tearlab Corp | $34.27 | 2022-2023 | Tearlab Osmolarity System |
| Oyster Point Pharma, INC. | $30.59 | 2022 | |
| Dompe US, INC. | $29.62 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $27.20 | 2023 | One Series Ultra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $15.21 | 2022 | |
| Allergan, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.